Infected blood products (FOI)
Infected blood products (FOI)Produced by the Freedom of Information office
Authored by Government of Jersey and published on 20 December 2022.
Prepared internally, no external costs.
Were any of the batches identified as infected blood by UK authorities supplied to the Jersey Health service and administered by hospital teams to any patients treated for any reason on the island of Jersey during the period 1975 through to 1995?
Prior to 1992, Jersey General Hospital utilised blood products from the UK National Blood Transfusion Service, and its associated manufacturing arm, BioProducts Laboratory.
The subject of contaminated UK blood products and Jersey’s use of blood products from the UK National Blood Transfusion Service and its associated manufacturing arm, BioProducts Laboratory, has been addressed in Ministerial Questions, as linked in a Freedom of Information response published in July 2022 on www.gov.je:
Haemophiliacs treated with infected blood (FOI)
As this information is accessible by other means, Article 23 of the Freedom of Information (Jersey) Law 2011 has been applied.
Article 23 - Information accessible to applicant by other means
(1) Information is absolutely exempt information if it is reasonably available to the applicant, otherwise than under this Law, whether or not free of charge.
(2) A scheduled public authority that refuses an application for information on this ground must make reasonable efforts to inform the applicant where the applicant may obtain the information.